Physicians Have Bigger Stake In Patients' Total Care Under Medicare ACOs
Executive Summary
One year after the passage of health care reform, recommendations around some of the more far-reaching elements of the legislation are beginning to emerge. One proposal biopharmas cannot afford to ignore: Medicare sanctioned accountable care organizations.
You may also be interested in...
Biologics Swing For The Fences: Payer Perspectives On Antibodies In Primary Care
Companies with large-molecule expertise increasingly are eyeing primary care markets, confident that improvements in safety and efficacy will make them competitive with oral standards of care.
Pharma In The Brave New World Of Corporatized Care
Still transforming their organizations to deal with the waning influence of the individual prescriber, pharma commercial leaders now face a new challenge: the growth of the corporate model of care, as large numbers of US physicians exchange the independence of physician-ownership for the predictability of working as employees in larger organizations. Corporate models of care, characterized by more centralized decision making, add a new dimension of customer complexity in an already tough environment.
Pharma In The Brave New World Of Corporatized Care
Still transforming their organizations to deal with the waning influence of the individual prescriber, pharma commercial leaders now face a new challenge: the growth of the corporate model of care, as large numbers of US physicians exchange the independence of physician-ownership for the predictability of working as employees in larger organizations. Corporate models of care, characterized by more centralized decision making, add a new dimension of customer complexity in an already tough environment.